ReviewVascular health and risk management2012

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.

Ola E DahlPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.